Vault-13

Exome Asset Management LLC

NEW YORK, NY · CIK 2011932 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2021 · limited liability company

As an employer

$162.1m reported value -4.6% vs Q1 2026
52positions
44.6%in top 10
15 new 1 added 32 reduced 8 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 GUARDANT HEALTH INC COM GH GH 67,500 $10.1m6.25% 6.25% ReducedShares held: Q3 2025 98.2k, Q4 2025 98.2k, Q1 2026 82.7k, Q2 2026 67.5k -15.2k -15,236 -18.4%
2 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 27,205 $9.1m5.62% 5.62% ReducedShares held: Q3 2025 102.0k, Q4 2025 58.1k, Q1 2026 45.5k, Q2 2026 27.2k -18.3k -18,264 -40.2%
3 TG THERAPEUTICS INC COM TGTX TGTX 164,915 $9.1m5.59% 5.59% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 164.9k
4 COGENT BIOSCIENCES INC COM COGT COGT 210,523 $8.1m5.03% 5.03% ReducedShares held: Q3 2025 443.5k, Q4 2025 305.6k, Q1 2026 278.5k, Q2 2026 210.5k -68.0k -68,010 -24.4%
5 IONIS PHARMACEUTICALS INC COM IONS IONS 88,177 $7.0m4.31% 4.31% ReducedShares held: Q3 2025 131.0k, Q4 2025 116.5k, Q1 2026 110.1k, Q2 2026 88.2k -21.9k -21,887 -19.9%
6 ELI LILLY & CO COM LLY LLY 5,492 $6.6m4.06% 4.06% ReducedShares held: Q3 2025 7.9k, Q4 2025 7.9k, Q1 2026 7.0k, Q2 2026 5.5k -1.5k -1,520 -21.7%
7 ABIVAX SA SPONSORED ADS ABVX ABVX 46,878 $6.2m3.85% 3.85% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 46.9k
8 ALUMIS INC COM ALMS ALMS 204,418 $5.8m3.55% 3.55% ReducedShares held: Q3 2025 292.8k, Q4 2025 292.2k, Q1 2026 279.2k, Q2 2026 204.4k -74.8k -74,758 -26.8%
9 CYTOKINETICS INC COM NEW CYTK CYTK 60,056 $5.1m3.16% 3.16% ReducedShares held: Q3 2025 142.4k, Q4 2025 124.7k, Q1 2026 103.7k, Q2 2026 60.1k -43.7k -43,662 -42.1%
10 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 100,203 $5.1m3.14% 3.14% ReducedShares held: Q3 2025 0, Q4 2025 222.3k, Q1 2026 220.1k, Q2 2026 100.2k -119.9k -119,888 -54.5%
11 VERA THERAPEUTICS INC CL A VERA VERA 97,276 $4.2m2.57% 2.57% ReducedShares held: Q3 2025 156.1k, Q4 2025 124.4k, Q1 2026 115.0k, Q2 2026 97.3k -17.7k -17,715 -15.4%
12 UNITEDHEALTH GROUP INC COM UNH UNH 9,612 $4.0m2.46% 2.46% ReducedShares held: Q3 2025 0, Q4 2025 5.8k, Q1 2026 12.9k, Q2 2026 9.6k -3.2k -3,250 -25.3%
13 10X GENOMICS INC CL A COM TXG TXG 102,629 $3.9m2.43% 2.43% ReducedShares held: Q3 2025 163.7k, Q4 2025 163.7k, Q1 2026 154.2k, Q2 2026 102.6k -51.6k -51,565 -33.4%
14 NATERA INC COM NTRA NTRA 13,800 $3.7m2.31% 2.31% ReducedShares held: Q3 2025 18.6k, Q4 2025 18.6k, Q1 2026 18.6k, Q2 2026 13.8k -4.8k -4,850 -26.0%
15 UNIQURE NV SHS QURE QURE 81,056 $3.7m2.30% 2.30% NewShares held: Q3 2025 22.1k, Q4 2025 0, Q1 2026 0, Q2 2026 81.1k
16 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 32,209 $3.6m2.21% 2.21% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 40.6k, Q2 2026 32.2k -8.4k -8,372 -20.6%
17 MAZE THERAPEUTICS INC COM MAZE MAZE 114,692 $3.4m2.11% 2.11% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 88.5k, Q2 2026 114.7k +26.2k +26,182 29.6%
18 MONTE ROSA THERAPEUTICS INC COM GLUE GLUE 137,115 $3.3m2.05% 2.05% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 179.5k, Q2 2026 137.1k -42.4k -42,369 -23.6%
19 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 166,493 $3.2m2.00% 2.00% ReducedShares held: Q3 2025 178.1k, Q4 2025 0, Q1 2026 215.4k, Q2 2026 166.5k -48.9k -48,883 -22.7%
20 ALKERMES PLC SHS ALKS ALKS 61,336 $3.2m1.98% 1.98% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 84.1k, Q2 2026 61.3k -22.8k -22,767 -27.1%
21 LIQUIDIA CORPORATION COM NEW LQDA LQDA 39,224 $3.1m1.93% 1.93% ReducedShares held: Q3 2025 94.2k, Q4 2025 91.1k, Q1 2026 45.8k, Q2 2026 39.2k -6.6k -6,572 -14.3%
22 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 5,410 $2.9m1.81% 1.81% ReducedShares held: Q3 2025 6.6k, Q4 2025 7.7k, Q1 2026 7.1k, Q2 2026 5.4k -1.6k -1,643 -23.3%
23 GLAUKOS CORP COM GKOS GKOS 19,862 $2.8m1.71% 1.71% ReducedShares held: Q3 2025 27.1k, Q4 2025 31.5k, Q1 2026 20.9k, Q2 2026 19.9k -1.0k -1,012 -4.8%
24 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 32,214 $2.6m1.62% 1.62% ReducedShares held: Q3 2025 104.5k, Q4 2025 49.8k, Q1 2026 45.7k, Q2 2026 32.2k -13.5k -13,507 -29.5%
25 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 70,500 $2.6m1.61% 1.61% ReducedShares held: Q3 2025 0, Q4 2025 136.9k, Q1 2026 125.1k, Q2 2026 70.5k -54.6k -54,560 -43.6%
26 CRESCENT BIOPHARMA INC. COM CBIO CBIO 127,769 $2.3m1.42% 1.42% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 153.2k, Q2 2026 127.8k -25.4k -25,422 -16.6%
27 ASTRAZENECA PLC ORD AZN AZN 12,045 $2.3m1.39% 1.39% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 12.0k
28 BOSTON SCIENTIFIC CORP COM BSX BSX 48,347 $2.1m1.27% 1.27% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 48.3k, Q2 2026 48.3k
29 ADAGENE INC ADS ADAG ADAG 488,293 $2.1m1.27% 1.27% ReducedShares held: Q3 2025 0, Q4 2025 1.1m, Q1 2026 736.8k, Q2 2026 488.3k -248.6k -248,552 -33.7%
30 PENUMBRA INC COM PEN PEN 6,300 $2.0m1.23% 1.23% UnchangedShares held: Q3 2025 9.0k, Q4 2025 9.0k, Q1 2026 6.3k, Q2 2026 6.3k
31 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 4,908 $2.0m1.20% 1.20% ReducedShares held: Q3 2025 6.4k, Q4 2025 6.4k, Q1 2026 6.4k, Q2 2026 4.9k -1.4k -1,450 -22.8%
32 VIKING THERAPEUTICS INC COM VKTX VKTX 47,861 $1.9m1.15% 1.15% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 47.9k
33 OCULAR THERAPEUTIX INC COM OCUL OCUL 181,588 $1.8m1.10% 1.10% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 181.6k
34 EQUILLIUM INC COM EQ EQ 552,956 $1.8m1.09% 1.09% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 553.0k
35 ASCENDIS PHARMA A/S ORD SHS ASND ASND 6,573 $1.8m1.08% 1.08% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 6.6k
36 CORBUS PHARMACEUTICALS HLDGS COM NEW CRBP CRBP 184,914 $1.7m1.07% 1.07% ReducedShares held: Q3 2025 230.0k, Q4 2025 139.5k, Q1 2026 234.1k, Q2 2026 184.9k -49.2k -49,222 -21.0%
37 CYTOMX THERAPEUTICS INC COM CTMX CTMX 460,067 $1.7m1.06% 1.06% ReducedShares held: Q3 2025 745.3k, Q4 2025 745.3k, Q1 2026 521.5k, Q2 2026 460.1k -61.4k -61,401 -11.8%
38 VERASTEM INC COM NEW VSTM VSTM 429,041 $1.6m1.01% 1.01% ReducedShares held: Q3 2025 0, Q4 2025 401.7k, Q1 2026 636.7k, Q2 2026 429.0k -207.7k -207,659 -32.6%
39 NEKTAR THERAPEUTICS COM NEW NKTR NKTR 22,417 $1.6m0.97% 0.97% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 22.4k
40 CLEARPOINT NEURO INC COM CLPT CLPT 83,636 $1.5m0.92% 0.92% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 83.6k
41 INSMED INC COM PAR $.01 INSM INSM 13,873 $1.5m0.91% 0.91% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 26.7k, Q2 2026 13.9k -12.8k -12,778 -48.0%
42 CARIS LIFE SCIENCES INC COM CAI CAI 78,180 $1.4m0.86% 0.86% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 78.2k
43 BRIDGEBIO PHARMA INC COM BBIO BBIO 18,359 $1.4m0.84% 0.84% ReducedShares held: Q3 2025 133.1k, Q4 2025 80.7k, Q1 2026 67.5k, Q2 2026 18.4k -49.1k -49,133 -72.8%
44 ZENAS BIOPHARMA INC COM ZBIO ZBIO 52,443 $1.3m0.82% 0.82% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 80.7k, Q2 2026 52.4k -28.3k -28,287 -35.0%
45 I MAB SPONSORED ADS NBP NBP 576,960 $1.1m0.69% 0.69% UnchangedShares held: Q3 2025 1.4m, Q4 2025 499.6k, Q1 2026 577.0k, Q2 2026 577.0k
46 ESTABLISHMENT LABS HLDGS INC COM ESTA ESTA 13,100 $1.1m0.69% 0.69% UnchangedShares held: Q3 2025 13.1k, Q4 2025 13.1k, Q1 2026 13.1k, Q2 2026 13.1k
47 RELAY THERAPEUTICS INC COM RLAY RLAY 47,531 $889.3k0.55% 0.55% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 278.3k, Q2 2026 47.5k -230.8k -230,771 -82.9%
48 GERON CORP COM GERN GERN 624,046 $798.8k0.49% 0.49% NewShares held: Q3 2025 1.9m, Q4 2025 0, Q1 2026 0, Q2 2026 624.0k
49 BRIGHT MINDS BIOSCIENCES INC COM NEW DRUG DRUG 10,110 $709.7k0.44% 0.44% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 10.1k
50 COMPASS THERAPEUTICS INC COM CMPX CMPX 276,165 $604.8k0.37% 0.37% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 276.2k
51 REPLIMUNE GROUP INC COM REPL REPL 40,361 $446.8k0.28% 0.28% NewShares held: Q3 2025 73.6k, Q4 2025 0, Q1 2026 0, Q2 2026 40.4k
52 ARBUTUS BIOPHARMA CORP COM ABUS ABUS 50,166 $240.8k0.15% 0.15% ReducedShares held: Q3 2025 75.5k, Q4 2025 75.5k, Q1 2026 75.5k, Q2 2026 50.2k -25.3k -25,318 -33.5%

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
ELEVANCE HEALTH INC ELV ELV 14,677 $4.3m14.7k shares
APELLIS PHARMACEUTICALS INC APLS APLS 85,517 $3.4m85.5k shares
AVALO THERAPEUTICS INC AVTX AVTX 159,341 $2.4m159.3k shares
SOLENO THERAPEUTICS INC SLNO SLNO 61,673 $2.1m61.7k shares
4D MOLECULAR THERAPEUTICS IN FDMT FDMT 130,564 $1.2m130.6k shares
NEXTCURE INC NXTC NXTC 115,500 $1.2m115.5k shares
PALISADE BIO INC PALI PALI 600,000 $1.1m600.0k shares
LIPOCINE INC NEW LPCN LPCN 60,861 $486.3k60.9k shares